Tag: ANDA patent challenge
Paragraph IV Certifications: How Generics Challenge Drug Patents
Discover how Paragraph IV certifications allow generic manufacturers to legally challenge drug patents. Learn about the Hatch-Waxman Act, the 180-day exclusivity reward, and the high-stakes litigation risks involved.
Categories: Medications
0